Delivery Order SPE2DR25D1104-SPE2DR26FK718
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,686.62 to AmerisourceBergen Drug Corp for 100 tablets of Glimepiride 4 mg on November 25, 2025, with completion scheduled for November 26, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Glimepiride is an oral antidiabetic medication commonly used in military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $10,454.95 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, and no set-aside designation was applied. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location. This award is...
- The Defense Logistics Agency awarded a delivery order valued at $1,799.68 to AmerisourceBergen Drug Corp for Glimepiride 1 mg tablets in quantities of 100 units. The contract is a firm fixed price delivery order with an ultimate completion date of December 8, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Glimepiride is an oral medication used in the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $19,739.94 for 100 tablets of Glimepiride 4 mg on August 25, 2025, with completion anticipated by August 26, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Glimepiride is an oral antidiabetic medication commonly utilized in military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100 units at a ceiling value of $1,606.70. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 19,...
- The Defense Logistics Agency awarded a delivery order valued at $1,750.74 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a $9,495.65 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Glimepiride is a sulfonylurea medication commonly prescribed for type 2 diabetes management, making this procurement part of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,665.28 for 100 tablets of Glimepiride 4 mg on December 17, 2025, with an ultimate completion date of December 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price terms and is performed at the contractor's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.49 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count packaging) under a firm fixed-price contract. The award, issued on December 5, 2025, with completion targeted for December 8, 2025, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $3,846.63 for Glimepiride 4 mg tablets (100-count units) on April 30, 2025, with an ultimate completion date of May 1, 2025. This competitively awarded contract utilizes firm fixed pricing with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK718Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) under a firm fixed-price contract valued at $1,229.86. The award was made on December 18, 2025, with an ultimate completion date of December 19, 2025. This non-set-aside delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Glimepiride is a diabetes management medication commonly used by federal healthcare systems to treat beneficiaries across the military and veteran healthcare networks. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999 and running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs. The company holds extensive federal contract awards with the Defense Logistics Agency and its Medical Supply Chain, supplying a broad portfolio of pharmaceutical products and medical supplies including brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. All reviewed contract awards demonstrate competitive award processes, reflecting the contractor's capability to meet federal procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/17/25 |